|
FEI Testing in
Eventing
March 5, 2004
Further to recent media attention in
relation to the use of prohibited medication (i.e. sedatives) in Eventing,
the FEI would like provide the following update. In 2003, FEI responded
immediately to rumours circulating about the use of sedatives in the
Dressage test of Eventing and the subsequent use of 'reversal' agents prior
to the cross-country.
The Federation took this matter
seriously and discussed it in detail during its April 2003 Bureau Meeting.
Further to consultation with the Veterinary Committee, the Medication
Sub-Committee and the FEI Veterinary department, it was decided to increase
the testing activities during several major events.
The CCI 4* Burghley was selected
and the number of horses tested was significantly increased (15 horses).
Samples were taken after the Dressage, after the Cross-Country test and on
the last day of the event. Informed on possible substances that could be
used to this effect, the laboratory confirmed that the detection of these
substances did not represent any analytical difficulty. No prohibited
substances were detected in these samples, with the exception of one Bute
positive, which was dealt with through the normal FEI Legal procedure.
No background information or
facts surrounding the rumours of the use of sedatives in Eventing Dressage
were reported either to the FEI Secretariat or to the Judicial Committee.
Since its foundation, the FEI particularly concerns itself with the welfare
of the horse, as shown in its Code of Conduct and Mission statement. The FEI
has extensive Medication Control activities (more than 2000 horses were
tested in 2003 by the FEI, in addition to thousands of tests carried out by
National Federations). The FEI list of prohibited substances is constantly
under review and regularly updated.
Further to its recent
investigations, the FEI is confident that the speculations about
administration of tranquilisers in Eventing Dressage are unsubstantiated.
Nevertheless, the FEI has taken note of the current discussions in the
Eventing community, and will continue to focus its testing activities
accordingly.
|